With NP2's involvement in neurodegenerative diseases and its potential role as a biomarker and therapeutic target, further research is needed to fully understand the mechanisms by which NP2 interacts with TDP-43 and contributes to ALS pathology. Here, TARDBP is linked to amyotrophic lateral sclerosis.